Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study ; day:17 ; month:4 ; year:2021 ; pages:1-7
Journal of neurology ; (17.4.2021), 1-7
- Urheber
-
Donzuso, Giulia
Sciacca, Giorgia
Rascunà, Cristina
Cicero, Calogero E.
Mostile, Giovanni
Nicoletti, Alessandra
Zappia, Mario
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-021-10550-5
- URN
-
urn:nbn:de:101:1-2021060510555901143642
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Donzuso, Giulia
- Sciacca, Giorgia
- Rascunà, Cristina
- Cicero, Calogero E.
- Mostile, Giovanni
- Nicoletti, Alessandra
- Zappia, Mario
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Model-based optimization of controlled release formulation of levodopa for Parkinson’s disease